An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults

SARS-CoV-2 Omicron subvariants have become the predominantly strain in most countries. However, the neutralizing activity of the human serum after Omicron-based vaccine booster against different SARS-CoV-2 variants is poorly understood. Here, we developed an update Omicron vaccine (SCoK-Omicron), ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tao, Luo, Deyan, Ning, Nianzhi, Wang, Xin, Zhang, Liangyan, Yang, Xiaolan, Li, Deyu, Sun, Yakun, Yu, Wenjing, Wei, Wenjin, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259307/
https://www.ncbi.nlm.nih.gov/pubmed/37272331
http://dx.doi.org/10.1080/22221751.2023.2207670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259307/
https://www.ncbi.nlm.nih.gov/pubmed/37272331
http://dx.doi.org/10.1080/22221751.2023.2207670

Ejemplares similares